TissGDB
Tissglogo

Home

Download

 Statistics

 Landscape

Help

Contact

Bioinformatics and Systems Medicine Laboratory Bioinformatics and Systems Medicine Laboratory

bullet point

TissGeneSummary

bullet point

TissGeneExp

bullet point

TissGene-miRNA

bullet point

TissGeneMut: TissGeneSNV, TissGeneCNV, and TissGeneFusions

bullet point

TissGeneNet

bullet point

TissGeneProg

bullet point

TissGeneClin: TissGeneDrug and TissGeneDisease

TissGeneSummary for HAMP
check button Gene summary
Basic gene informationGene symbolHAMP
Gene namehepcidin antimicrobial peptide
SynonymsHEPC|HFE2B|LEAP1|PLTR
CytomapUCSC genome browser: 19q13.1
Type of geneprotein-coding
RefGenesNM_021175.2,
Descriptionhepcidinliver-expressed antimicrobial peptide 1putative liver tumor regressor
Modification date20141222
dbXrefs MIM : 606464
HGNC : HGNC
HPRD : 05925
ProteinUniProt:
go to UniProt's Cross Reference DB Table
ExpressionCleanEX: HS_HAMP
BioGPS: 57817
PathwayNCI Pathway Interaction Database: HAMP
KEGG: HAMP
REACTOME: HAMP
Pathway Commons: HAMP
ContextiHOP: HAMP
ligand binding site mutation search in PubMed: HAMP
UCL Cancer Institute: HAMP
Assigned class in TissGDB*C
Included tissue-specific gene expression resourcesHPA,GTEx
Specific-tissues in normal samples (assigned by TissGDB using HPA, TiGER, and GTEx)Liver
Cancer types related to the specific-tissues in cancer samples (assigned by TissGDB using TCGA)LIHC
Reference showing the relevant tissue of HAMP
Description by TissGene annotationsCancer gene
* Class A consists of genes with literature evidence and is part of the cTissGenes. Class B consists of only cTissGenes without additional evidence. The remaining genes belong to Class C.

check button Gene ontology having evidence of Inferred from Direct Assay (IDA) from Entrez
GO IDGO termPubMed ID


Top
TissGeneExp for HAMP

check button Gene expressions across 28 cancer types (X-axis: cancer type and Y-axis: log2(norm_counts+1))
(TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16)
gene exp


check button Gene isoform expressions across 28 cancer types (X-axis: cancer type and Y-axis: log2(norm_counts+1))
(TCGA pan-cancer tcga_rsem_isoform_tpm, version 2016-09-01)
gene isoform exp


check button Gene expressions across normal tissues of GTEx data
(GTEx GTEx_Analysis_v6_RNA-seq_RNA-SeQCv1.1.8_gene_rpkm.gct)
- Here, we shows the matched tissue types only among our 28 cancer types.
normal gene exp


check button Different expressions across 14 cancer types with more than 10 samples between matched tumors and normals (X-axis: cancer type and Y-axis: log2(norm_counts+1))
(TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16)
DEG exp

- Significantly differentially expressed cancer types and information. (|Fold change|>1 and FDR<0.05)
Cancer typeMean(exp) in tumorMean(exp) in matched normalLog2FCP-val.FDR
KIRP1.416921541-3.4932409594.91016252.75E-169.94E-15
KICH-1.665614709-3.5321147091.86652.21E-056.54E-05
LIHC1.5355192919.234607291-7.6990886.24E-193.46E-17
LUAD-0.400755399-2.0440881581.6433327598.45E-072.86E-06
KIRC-0.846194432-3.5995291542.7533347221.89E-171.18E-16
STAD-1.553437834-3.1724909591.6190531250.0002560.001723784
COAD-1.776723171-3.2318924021.4551692310.0003430.001098703
LUSC-0.4199602-1.5619876511.1420274510.0003510.000690955


Top
TissGene-miRNA for HAMP

check button Significantly anti-correlated miRNAs of TissGene across 28 cancer types
(Gene-miRNA relations from TargetScanHuman Relsease 7.1, Conserved_Site_Context_Scores.txt.zip, 06.01.2016)
(TCGA IlluminaHiSeq_miRNASeq, log2(RPM+1) data, version 2016-11-21)
(TCGA IlluminaHiSeq_RNASeqV2, log2(normalized_count+1) data, version 2016-08-16)
(Spearman’s Rank Correlation (p-value<0.05 and coefficient<-0.25))
Cancer typemiRNA idmiRNA accessionP-val.Coeff.# samples


Top
TissGeneMut for HAMP
TissGeneSNV for HAMP

check button nsSNV counts per each loci.
Different colors of circles represent different cancer types. Circle size denotes number of samples.
(TCGA somatic mutation (SNPs and small INDELs) data, version 2016-04-25)

* Click on the image to enlarge it in a new window.
SNV lollipop
bullet point


check button Somatic nucleotide variants of TissGene across 28 cancer types
(X-axis: cancer type and Y-axis: % of mutated samples)
The numbers in parentheses are numbers of samples with mutation (nsSNVs).
(TCGA somatic mutation (SNPs and small INDELs) data, version 2016-04-25)
SNV distribution

- nsSNVs sorted by frequency.
AAchangeCancer type# samples
p.W49*SKCM1
p.S48GCHOL1
p.Q54HBRCA1
p.R56QSKCM1
p.H74YSKCM1
p.T61NLUAD1
p.E36XKIRP1
p.W8GKIRC1
p.K83NTHYM1


Top
TissGeneCNV for HAMP

check button Copy number variations of TissGene across 28 cancer types (X-axis: cancer type and Y-axis: % of CNV samples)
(TCGA Gistic2_CopyNumber_Gistic2_all_data_by_genes, Gistic2 copy number data, version 2016-08-16)
CNV


Top
TissGeneFusions for HAMP

check button Fusion genes including TissGene
(ChimerDB 3.0, 2016-12-01 and TCGA fusion Portal 2015-12-01)
DatabaseSrcCancer typeSampleFusion geneORF5'-gene BP3'-gene BP


Top
TissGeneNet for HAMP

check button Co-expressed gene networks based on protein-protein interaction data (CePIN)
(TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16)
(PINA2 ppi data)
BRCA (tumor)BRCA (normal)
HAMP, CKAP4, GATA4, SLC40A1, GATA6 (tumor)HAMP, CKAP4, GATA4, SLC40A1, GATA6 (normal)
bullet pointbullet point
COAD (tumor)COAD (normal)
HAMP, CKAP4, GATA4, SLC40A1, GATA6 (tumor)HAMP, CKAP4, GATA4, SLC40A1, GATA6 (normal)
bullet pointbullet point
HNSC (tumor)HNSC (normal)
HAMP, CKAP4, GATA4, SLC40A1, GATA6 (tumor)HAMP, CKAP4, GATA4, SLC40A1, GATA6 (normal)
bullet pointbullet point
KICH (tumor)KICH (normal)
HAMP, CKAP4, GATA4, SLC40A1, GATA6 (tumor)HAMP, CKAP4, GATA4, SLC40A1, GATA6 (normal)
bullet pointbullet point
KIRC (tumor)KIRC (normal)
HAMP, CKAP4, GATA4, SLC40A1, GATA6 (tumor)HAMP, CKAP4, GATA4, SLC40A1, GATA6 (normal)
bullet pointbullet point
KIRP (tumor)KIRP (normal)
HAMP, CKAP4, GATA4, SLC40A1, GATA6 (tumor)HAMP, CKAP4, GATA4, SLC40A1, GATA6 (normal)
bullet pointbullet point
LIHC (tumor)LIHC (normal)
HAMP, CKAP4, GATA4, SLC40A1, GATA6 (tumor)HAMP, CKAP4, GATA4, SLC40A1, GATA6 (normal)
bullet pointbullet point
LUAD (tumor)LUAD (normal)
HAMP, CKAP4, GATA4, SLC40A1, GATA6 (tumor)HAMP, CKAP4, GATA4, SLC40A1, GATA6 (normal)
bullet pointbullet point
LUSC (tumor)LUSC (normal)
HAMP, CKAP4, GATA4, SLC40A1, GATA6 (tumor)HAMP, CKAP4, GATA4, SLC40A1, GATA6 (normal)
bullet pointbullet point
PRAD (tumor)PRAD (normal)
HAMP, CKAP4, GATA4, SLC40A1, GATA6 (tumor)HAMP, CKAP4, GATA4, SLC40A1, GATA6 (normal)
bullet pointbullet point
STAD (tumor)STAD (normal)
HAMP, CKAP4, GATA4, SLC40A1, GATA6 (tumor)HAMP, CKAP4, GATA4, SLC40A1, GATA6 (normal)
bullet pointbullet point
THCA (tumor)THCA (normal)
HAMP, CKAP4, GATA4, SLC40A1, GATA6 (tumor)HAMP, CKAP4, GATA4, SLC40A1, GATA6 (normal)
bullet pointbullet point


Top
TissGeneProg for HAMP

check button Kaplan-Meier plots with logrank tests of overall survival (OS) using 28 cancer types
(TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16)
(TCGA clinicalMatrix, phenotype data, version 2016-04-27)

* Click on the image to enlarge it in a new window.
survival 1

check button Kaplan-Meier plots with logrank test of relapse free survival (RFS) using 28 cancer types
(TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16)
(TCGA clinicalMatrix, phenotype data, version 2016-04-27)

* Click on the image enlarge it in a new window.
survival 2

check button Forest plot of Cox proportional hazard ratio (HR) and 95% CI of overall survival (OS) using 28 cancer types
(TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16)
(TCGA clinicalMatrix, phenotype data, version 2016-04-27)

* Click on the image enlarge it in a new window.
survival 3

check button Forest plot of Cox proportional hazard ratio (HR) and 95% CI of relapse free survival (RFS) using 28 cancer types
(TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16)
(TCGA clinicalMatrix, phenotype data, version 2016-04-27)

* Click on the image enlarge it in a new window.
survival 4

Top
TissGeneClin for HAMP
TissGeneDrug for HAMP

check button Drug information targeting TissGene
(DrugBank Version 5.0.6, 2017-04-01)
DrugBank IDDrug nameDrug activityDrug typeDrug status


Top
TissGeneDisease for HAMP

check button Disease information associated with TissGene
(DisGeNet, 2016-06-01)
Disease IDDisease name# pubmedsSource
umls:C0282193Iron Overload104BeFree,CTD_human,GAD,LHGDN
umls:C0018995Hemochromatosis73BeFree,CTD_human,GAD,LHGDN
umls:C0002871Anemia65BeFree,CTD_human,LHGDN
umls:C0392514Hereditary hemochromatosis48BeFree,CLINVAR
umls:C0268060Juvenile hemochromatosis27BeFree,CTD_human,ORPHANET
umls:C0240066Iron deficiency23BeFree
umls:C0002873Anemia of chronic disease18BeFree
umls:C2239176Liver carcinoma18BeFree
umls:C0005283beta Thalassemia14BeFree,CTD_human,GAD
umls:C0023903Liver neoplasms13BeFree
umls:C0039730Thalassemia11BeFree,LHGDN
umls:C0085576Iron-Refractory Iron Deficiency Anemia11BeFree
umls:C0162316Iron deficiency anemia10BeFree
umls:C0019196Hepatitis C9BeFree,LHGDN
umls:C0002875Cooley's anemia8BeFree
umls:C0028754Obesity8BeFree
umls:C0012715Iron Metabolism Disorders7BeFree,GAD
umls:C0524910Hepatitis C, Chronic6BeFree
umls:C0023896Alcoholic Liver Diseases5BeFree
umls:C0004623Bacterial Infections4BeFree
umls:C0022661Kidney Failure, Chronic4BeFree,CTD_human,LHGDN
umls:C0023895Liver diseases4BeFree
umls:C0472767Beta thalassemia intermedia4BeFree
umls:C0524620Metabolic Syndrome X4BeFree
umls:C0878682Ceruloplasmin deficiency4BeFree
umls:C0002895Anemia, Sickle Cell3BeFree
umls:C0003873Rheumatoid Arthritis3BeFree,LHGDN
umls:C0011847Diabetes3BeFree
umls:C0011849Diabetes Mellitus3BeFree
umls:C0023890Liver Cirrhosis3BeFree
umls:C0024530Malaria3BeFree,LHGDN
umls:C0162309Adrenoleukodystrophy3BeFree
umls:C0596263Carcinogenesis3BeFree
umls:C1865616HEMOCHROMATOSIS, TYPE 2B3CLINVAR,CTD_human,UNIPROT
umls:C0003850Arteriosclerosis2BeFree
umls:C0004153Atherosclerosis2BeFree
umls:C0005411Biliary Atresia2BeFree,CTD_human
umls:C0006142Malignant neoplasm of breast2BeFree
umls:C0009319Colitis2BeFree
umls:C0014130Endocrine System Diseases2BeFree
umls:C0019693HIV Infections2BeFree
umls:C0021368Inflammation2LHGDN
umls:C0024535Malaria, Falciparum2BeFree,LHGDN
umls:C0026764Multiple Myeloma2BeFree
umls:C0029928Ovarian Diseases2BeFree
umls:C0035078Kidney Failure2BeFree
umls:C0037061Siderosis2BeFree,LHGDN
umls:C0042769Virus Diseases2BeFree
umls:C0239946Fibrosis, Liver2BeFree
umls:C0271901Microcytic hypochromic anemia (disorder)2BeFree
umls:C0341439Chronic liver disease2BeFree
umls:C0400966Non-alcoholic Fatty Liver Disease2BeFree
umls:C0403447Chronic Kidney Insufficiency2BeFree
umls:C0497406Overweight2BeFree
umls:C0678222Breast Carcinoma2BeFree
umls:C0878521Beta thalassemia trait2BeFree
umls:C1561643Chronic Kidney Diseases2BeFree
umls:C1623038Cirrhosis2BeFree
umls:C1858664HEMOCHROMATOSIS, TYPE 32BeFree
umls:C2316810Chronic kidney disease stage 52BeFree
umls:C3241937Nonalcoholic Steatohepatitis2BeFree
umls:C0000786Spontaneous abortion1GAD
umls:C0001430Adenoma1BeFree,LHGDN
umls:C0002893Refractory anemias1BeFree
umls:C0004114Astrocytoma1BeFree
umls:C0008313Cholangitis, Sclerosing1BeFree
umls:C0009404Colorectal Neoplasms1LHGDN
umls:C0011860Diabetes Mellitus, Non-Insulin-Dependent1BeFree
umls:C0017152Gastritis1BeFree
umls:C0019163Hepatitis B1BeFree
umls:C0019202Hepatolenticular Degeneration1CTD_human
umls:C0021390Inflammatory Bowel Diseases1BeFree
umls:C0022658Kidney Diseases1BeFree
umls:C0024141Lupus Erythematosus, Systemic1LHGDN
umls:C0024299Lymphoma1BeFree
umls:C0028756Obesity, Morbid1BeFree
umls:C0031154Peritonitis1BeFree
umls:C0032460Polycystic Ovary Syndrome1BeFree
umls:C0032461Polycythemia1BeFree
umls:C0032708Disorders of Porphyrin Metabolism1LHGDN
umls:C0032962Pregnancy Complications1GAD
umls:C0033027Preleukemia1BeFree
umls:C0036117Salmonella infections1BeFree
umls:C0041296Tuberculosis1BeFree
umls:C0149520Acute Cholecystitis1BeFree
umls:C0162566Porphyria Cutanea Tarda1BeFree,LHGDN
umls:C0238644Anemia, severe1BeFree
umls:C0242379Malignant neoplasm of lung1BeFree
umls:C0242723Parasitemia1BeFree
umls:C0268070Hypocupremia1BeFree
umls:C0271979Thalassemia Intermedia1BeFree
umls:C0275553Bacterial cholangitis1BeFree
umls:C0342793Malonic aciduria1BeFree
umls:C0376358Malignant neoplasm of prostate1BeFree
umls:C0472777Hemoglobin E/beta thalassemia disease1BeFree
umls:C0524909Hepatitis B, Chronic1BeFree
umls:C0566602Primary sclerosing cholangitis1BeFree
umls:C0600139Prostate carcinoma1BeFree
umls:C0684249Carcinoma of lung1BeFree
umls:C0740340Amyloidosis, Familial1LHGDN
umls:C0746102Chronic lung disease1BeFree
umls:C1142276Renal anemia1BeFree
umls:C1290884Inflammatory disorder1BeFree
umls:C1334815Multi-centric Castleman's Disease1BeFree
umls:C1458155Mammary Neoplasms1BeFree
umls:C1565489Renal Insufficiency1BeFree
umls:C1636149Macular dystrophy, corneal type 11BeFree
umls:C1961102Precursor Cell Lymphoblastic Leukemia Lymphoma1GAD
umls:C2981142Refractory anemia, without ringed sideroblasts, without excess blasts1BeFree
umls:C3463824MYELODYSPLASTIC SYNDROME1BeFree
umls:C3714514Infection1LHGDN